ABSTRACT
Joint arthroplasty in younger patients (defined as those under 50-55 years) presents with a different set of issues from those in the usual 55-75 years age group. These relate not only to the obvious issue of longevity or survival of the implant, but also to the likelihood of future revision surgery and its implications for bone stock. Younger patients tend to be high demand.
